Vildagliptin 100mg SR Tablets

Vildagliptin 100mg is a DPP-4 inhibitor used to improve blood glucose control in type 2 diabetes. It supports meal-related insulin responses and can be used alone or with other glucose-lowering medicines.
Swallow the prolonged-release tablet whole with water, with or without food, at the same time each day. Do not crush or chew it. A 100mg prolonged-release product should not be exchanged for immediate-release tablets by matching tablet count alone.
Vildagliptin inhibits DPP-4, prolonging the action of incretin hormones. This increases insulin release and reduces glucagon secretion when glucose is elevated, lowering fasting and post-meal glucose.
Headache, dizziness, nausea and low blood glucose can occur, particularly with insulin or a sulfonylurea. Persistent severe abdominal pain, jaundice or skin blistering needs prompt assessment.
Liver enzymes are measured before and during treatment because liver injury can occur. Kidney impairment can require dose reduction. Previous pancreatitis is relevant. Vildagliptin does not replace insulin in type 1 diabetes and does not treat ketoacidosis.
Improves fasting and post-meal glucose through glucose-dependent hormone effects, with relatively low hypoglycaemia risk when used alone.
The risk is relatively low alone because its insulin effect depends on glucose. Insulin and sulfonylureas increase the risk when combined with it.
They are different medicines in the DPP-4 inhibitor class and are not dose-for-dose interchangeable.
Uncommon liver injury can develop without early symptoms, so blood tests help detect changes.
Vildagliptin is generally weight-neutral; it is not a weight-loss medicine.
Severe persistent upper abdominal pain, especially with vomiting or pain spreading to the back, can indicate pancreatitis.
DPP-4 inhibitor: a medicine that prolongs incretin hormone activity. Incretin: a gut hormone involved in meal-related insulin release. Glucagon: a hormone that raises blood glucose. Hypoglycaemia: abnormally low blood glucose; AR: Vildagliptin 100mg أقراص ممتدة التحرر; FR: Vildagliptin 100mg comprimés à libération prolongée; PT: Vildagliptin 100mg comprimidos de libertação prolongada; ES: Vildagliptin 100mg comprimidos de liberación prolongada; RU: Vildagliptin 100mg таблетки пролонгированного высвобождения; ID: Vildagliptin 100mg tablet lepas lambat; VI: Vildagliptin 100mg viên nén giải phóng kéo dài; MS: Vildagliptin 100mg tablet pelepasan berpanjangan; TL: Vildagliptin 100mg tabletang may pinalawig na paglabas; ZH-SG: Vildagliptin 100mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Vildagliptin 100mg SR Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Vildagliptin 100mg SR Tablets